Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
This study is ongoing, but not recruiting participants.
Study NCT00020501 Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Metastatic Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
FOLFIRI regimen
floxuridine
fluorouracil
irinotecan hydrochloride
leucovorin calcium
melphalan
hyperthermia treatment
Additional drug interventions recognized in this trial
Camptothecin
Irinotecan
Leucovorin
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
